Neurologic Health Associates, PC
Your Subtitle text

Treatment Service

BOTOX Injection Therapy
At Neurologic Health Associates, we consider ourselves specialists in providing BOTOX injection therapy under electromyographic guidance for the treatment of dystonias, including torticollis and other conditions such as hemifacial spasm, blepharospasm and spasticity. We also use BOTOX injections for the treatment of chronic headaches as approved by the FDA.

Infusion Therapy
We provide infusion services for patients with Multiple Sclerosis, peripheral neuropathies, and acute headaches.

Diagnostic Services 
We offer a range of state-of-the-art diagnostics, including
  • EEG (electroencephalogram)
  • EMG/NCV studies (electromyogram and nerve conduction studies)
  • Evoked responses (visual, brainstem, and auditory)
  • Lumbar punctures
  • Neurotrax Cognitive testing
  • Quotient Testing for ADD/ADHD 

Conditions Treated 
The physicians at Neurologic Health Associates have trained in the full range of neurological concerns. Below is a list of links to the most commonly treated conditions. If your topic is not listed, please check out our Web Site Links Document for additional resources. 

  • Chronic pain/RSD
  • Migraine
  • Strokes
  • Seizures (epilepsy)
  • Headaches
  • Dementias (including Alzheimer's disease)
  • Multiple sclerosis (MS)
  • Parkinson's disease and other movement disorders
  • Neuropathy, including carpal tunnel syndrome
  • Sleep disorders
  • ADHD (attention deficit/hyperactivity disorder)

Clinical Research

  • X-linked Pure Familial Spastic Paraparesis: Characterization of a large kindred with Magnetic Resonance Imaging Studies; Archives of Neurology 7/95, Vol. 52:665-9
  • Astract accepted at ASNR Annual Meeting, "Familial Spastic Paraplegia:  MR Imaging of affected Individuals and Screening of Carriers"
  • Abstract accepted AAEM Annual Meeting, "The Detection of Sensory Abnormalities in Neurogenic Thoracic Outlet Syndrome using Quantitative Sensory Testing"
  • Principal Investigator, “The ACT Study” sponsored by Biogen Inc.,
  • Principal Investigator, “Trial SP742- Diabetic Peripheral Polyneuropathy” sponsored by Schwartz Biosciences “Trial SP745- Diabetic Peripheral Polyneuropathy” Extension
  • Sub Investigator, “ADD/ADHD in Adults” sponsored by Shire
  • Principal Investigator, “Protocol #191622-079 Headache prophylaxis In migraine patients” sponsored by Allergan
  • Principal Investigator, “CAPSS-311” sponsored by TIME
  • Principal Investigator, “ROBUST- Real World Betaseron Outcome Study” Sponsored by Bayer Pharmaceuticals
  • Principal Investigator, “ENERG- Effects of Natalizumab Treatment on Fatigue and Cognition”, sponsored by Biogen
  • Principal Investigator, “DVS 322/325 Diabetic Peripheral Polyneuropathy,” sponsored by Wyeth Pharmaceuricals
  • Principal Investigator, “Nabs Count- Neurtralizing Antibodies with Interferon therapy,” sponsored by Teva Pharmaceuticals
  • Principal Investigator, STRATIFY2:  JCV Antibody Program in Patients with Relapsing-Remitting Multiple Sclerosis Receiving or Considering Tysabri, sponsored by Biogen.